Newsroom

About

Cofactor Genomics was founded after the pioneering efforts of the Human Genome Project made high-throughput, affordable human genome sequencing a reality. The founders saw that analyzing RNA offered a number of advantages over the static nature of DNA (learn more here). Today, Cofactor works in partnership with medical centers, pharma companies, and clinical research organizations to offer the most advanced machine-learning tools, deep databases, and molecular reagents through our Predicti...
Cofactor Genomics was founded after the pioneering efforts of the Human Genome Project made high-throughput, affordable human genome sequencing a reality. The founders saw that analyzing RNA offered a number of advantages over the static nature of DNA (learn more here). Today, Cofactor works in partnership with medical centers, pharma companies, and clinical research organizations to offer the most advanced machine-learning tools, deep databases, and molecular reagents through our Predictive Immune Modeling platform which enables us to match patients with the therapies that will benefit them the most.

Press Contacts

Michelle McAdam, Chronic Communications Inc.
(310) 902-1274

Video

CofactorGenomics - Why RNA?
View on Vimeo

Resources (Files)

Cofactor Genomics Overview

Bios

Jarret Glasscock is a geneticist and computational biologist leading the team at Cofactor Genomics, a company pioneering the use of multidimensional RNA models in diagnostics. Dr. Glasscock’s work spans from earliest uses of next-gen RNA-seq data, to the first published cancer genome, and he has been covered in GEN, Wired, and Nature.
https://cdn.filestackcontent.com/qTsSa9etTSqdlTVVSBAt
Jarret Glasscock, PhD
Founder and CEO
View more >>
Dr. David Messina has spent the last 20 years working in computational biology and genetics. He worked on the Human Genome Project at Washington University in Saint Louis, mapped disease genes at the University of Chicago, and earned his PhD in computational biology in Stockholm, Sweden. As COO at Cofactor Genomics, he oversees daily operations and leads regulatory strategy.
https://cdn.filestackcontent.com/RnWqzrWERzOo584vj7z3
David Messina
Chief Operating Officer at Cofactor Genomics
View more >>
Natalie first joined Cofactor Genomics in 2013, with a PhD in Chemistry from Washington University in St. Louis. Natalie has developed customized experimental solutions for both DNA and RNA applications at Cofactor, as well as launched and supported diagnostic reference standards as a part of Horizon Discovery’s Diagnostics Division. Natalie now supports Cofactor’s clinical collaborations and outreach efforts as the VP of Market Development, with the goal of expanding the utility of Predictive Immune Modeling for cancer biomarker discovery.
https://cdn.filestackcontent.com/5O8FA40TRe5AE8BGkwPw
Natalie LaFranzo, PhD
Vice President of Market Development
View more >>

Social Accounts